Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2. Chen S, Wang Q, Bakker D, Hu X, et al. Basic Res Cardiol 2024 Jul 24. doi: 10.1007/s00395-024-01067.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chen S, Wang Q, Bakker D, Hu X, et al. Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2. Basic Res Cardiol 2024 Jul 24. doi: 10.1007/s00395-024-01067.
PMID: 39046464